Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

1,3-Benzodioxolylbutanamine

From Wikipedia, the free encyclopedia
Entactogen drug
Pharmaceutical compound
BDB
Clinical data
Other namesBDB; MDB; J; 3,4-Methylenedioxy-α-ethylphenethylamine; MDAEPEA; Benzodioxolylbutanamine; 3,4-Methylenedioxybutanphenamine
Routes of
administration
Oral[1]
Drug classSerotonin–norepinephrine releasing agent;Entactogen
Legal status
Legal status
Identifiers
  • 1-(1,3-benzodioxol-5-yl)butan-2-amine
CAS Number
PubChemCID
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC11H15NO2
Molar mass193.246 g·mol−1
3D model (JSmol)
Melting point159 to 161 °C (318 to 322 °F)
  • CCC(CC1=CC2=C(C=C1)OCO2)N
  • InChI=1S/C11H15NO2/c1-2-9(12)5-8-3-4-10-11(6-8)14-7-13-10/h3-4,6,9H,2,5,7,12H2,1H3
  • Key:VHMRXGAIDDCGDU-UHFFFAOYSA-N
  (verify)

1,3-Benzodioxolylbutanamine (BDB), also known as3,4-methylenedioxy-α-ethylphenethylamine or asJ, is anentactogen of thephenethylamine,phenylisobutylamine, andMDxx families related toMDMA.[1][2]

Use and effects

[edit]

In his bookPiHKAL (Phenethylamines I Have Known and Loved),Alexander Shulgin lists the dose range as 150 to 230 mgorally and theduration as 4 to 8 hours.[1] BDB produces entactogenic, MDMA-like effects.[1] Although pleasant andeuphoric, BDB is also fairlysedating and some users feel that the lack ofstimulant effect makes it less enjoyable than other similar drugs.[1] Additionalside effects associated with BDB includenystagmus anddizziness.[1] Very little data exists about thepharmacological properties,metabolism, andtoxicity of BDB.[1]

Interactions

[edit]
See also:MDMA § Interactions,Trip killer § Antidotes of other hallucinogens, andMDMA/citalopram

Pharmacology

[edit]

Pharmacodynamics

[edit]

Receptor andtransporter interaction data have been reported for BDB.[3][4] It acts as aserotonin–norepinephrine releasing agent (SNDRA) with only weak effects ondopamine.[4]Animal studies andanecdotal reports have found that BDB is a slightly morepotentserotonin releasing agent than itsmethylated sistercompoundmethylbenzodioxylbutanamine (MBDB; "Eden", "Methyl-J").[5]

Chemistry

[edit]

BDB, also known as 1,3-benzodioxolylbutanamine or as 3,4-methylenedioxy-α-ethylphenethylamine, is aphenethylamine,α-ethylphenethylamine (phenylisobutylamine), andmethylenedioxyphenethylamine (MDxx) related toMDMA.[1] It is theα-ethylanalogue of3,4-methylenedioxyphenethylamine (MDPEA) and3,4-methylenedioxyamphetamine (MDA) and the 3,4-methylenedioxyderivative ofα-ethylphenethylamine (AEPEA).[1]

Analogues

[edit]

Analogues of BDB includeMBDB (methyl-J),EBDB (ethyl-J),1,3-benzodioxolylpentanamine (BDP; K),MBDP (methyl-K),EBDP (ethyl-K), andMPAP (PDBP; propyl-K), among others.[1]

History

[edit]

BDB was first described in thescientific literature by at least 1973.[6]

Society and culture

[edit]

Recreational use

[edit]

Rather than as arecreational drug itself, BDB is more commonly known as ametabolite of theN-alkylated analogues MBDB andethylbenzodioxylbutanamine (EBDB; "Ethyl-J"), which have appeared in MDMA or "ecstasy" tablets.[7][8] Although BDB itself has not been reported as being sold as "ecstasy", urine analysis of users suggest that this drug may have appeared as a street drug, though it is unclear whether the positive urine test for BDB resulted from consumption of BDB itself or merely as a metabolite of MBDB.[9]

Legal status

[edit]

Germany

[edit]

BDB is illegal inGermany (Anlage I).

See also

[edit]

References

[edit]
  1. ^abcdefghijShulgin A,Shulgin A (September 1991).PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press.ISBN 0-9630096-0-5.OCLC 25627628.http://www.erowid.org/library/books_online/pihkal/pihkal094.shtml
  2. ^Bronson ME, Jiang W, DeRuiter J, Clark CR (1995). "A behavioral comparison of Nexus, cathinone, BDB, and MDA".Pharmacology, Biochemistry, and Behavior.51 (2–3):473–5.doi:10.1016/0091-3057(95)00013-m.PMID 7667371.S2CID 32246652.
  3. ^Kolaczynska KE, Ducret P, Trachsel D, Hoener MC, Liechti ME, Luethi D (June 2022)."Pharmacological characterization of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA".Eur Neuropsychopharmacol.59:9–22.doi:10.1016/j.euroneuro.2022.03.006.PMID 35378384.
  4. ^abNagai F, Nonaka R, Satoh Hisashi Kamimura K (March 2007). "The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain".Eur J Pharmacol.559 (2–3):132–137.doi:10.1016/j.ejphar.2006.11.075.PMID 17223101.
  5. ^Bronson ME, Jiang W, DeRuiter J, Clark CR (1995). "Structure-activity relationships of BDB and its monomethyl and dimethyl derivatives".Pharmacology, Biochemistry, and Behavior.51 (2–3):477–9.doi:10.1016/0091-3057(95)00012-l.PMID 7667372.S2CID 25332862.
  6. ^Hardman HF, Haavik CO, Seevers MH (June 1973). "Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals".Toxicol Appl Pharmacol.25 (2):299–309.Bibcode:1973ToxAP..25..299H.doi:10.1016/s0041-008x(73)80016-x.hdl:2027.42/33868.PMID 4197635.
  7. ^Kintz P (1997)."Excretion of MBDB and BDB in urine, saliva, and sweat following single oral administration".Journal of Analytical Toxicology.21 (7):570–5.doi:10.1093/jat/21.7.570.PMID 9399128.
  8. ^Garofano L, Santoro M, Patri P, Guidugli F, Bollani T, Favretto D, Traldi P (1998). "Ion trap mass spectrometry for the characterization of N-methyl-1- (3,4-methylene-dioxyphenyl)-2-butanamine and N-ethyl-3,4- methylenedioxyamphetamine, two widely distributed street drugs".Rapid Communications in Mass Spectrometry.12 (12):779–82.doi:10.1002/(SICI)1097-0231(19980630)12:12<779::AID-RCM233>3.0.CO;2-Q.PMID 9650303.
  9. ^Kronstrand R (October 1996)."Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users".Journal of Analytical Toxicology.20 (6):512–6.doi:10.1093/jat/20.6.512.PMID 8889691.

External links

[edit]
Phenethylamines
Non-ring-extended
Benzodioxoles
(methylenedioxy- or MDxx)
Benzodioxines
(ethylenedioxy-)
Benzofurans
Dihydrobenzofurans
Benzothiophenes
Benzothiazoles
Benzoxathioles
Indanes
Indoles
Naphthalenes
Tetralins
Others
Cyclized
phenethylamines
2-Aminoindanes
1-Aminomethylindanes
2-Aminotetralins
Aminorexes
Tryptamines
α-Alkyltryptamines
Others
Benzofurans
Benzothiophenes
Indolizines
Isotryptamines
Others
DRAsTooltip Dopamine releasing agents
NRAsTooltip Norepinephrine releasing agents
SRAsTooltip Serotonin releasing agents
Others
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=1,3-Benzodioxolylbutanamine&oldid=1323693090"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp